Repatha and Eating disorder - a phase IV clinical study of FDA data

Summary:

Eating disorder is reported as a side effect among people who take Repatha (evolocumab), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Tylenol, and have Hyperlipidaemia.

The phase IV clinical study analyzes which people have Eating disorder when taking Repatha. It is created by eHealthMe based on reports of 155,838 people who have side effects when taking Repatha from the FDA, and is updated regularly.

What is Repatha?

Repatha has active ingredients of evolocumab. It is often used in high blood cholesterol. eHealthMe is studying from 156,258 Repatha users. Check the latest studies of Repatha.

What is Eating disorder?

Eating disorder is found to be associated with 1,369 drugs and 1,447 conditions by eHealthMe. Check the latest studies of Eating disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

155,838 people reported to have side effects when taking Repatha.
Among them, 40 people (0.03%) have Eating disorder.

Among these 40 people:

How long have people been on Repatha when they have Eating disorder? *

What is the gender of people who have Eating disorder when taking Repatha? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Eating disorder when taking Repatha? *

What are other drugs people take besides Repatha? *

Tylenol: 4 people, 10.00%
Omeprazole: 3 people, 7.50%
Vitamin D3: 3 people, 7.50%
Pantoprazole: 3 people, 7.50%
Amlodipine Besylate: 3 people, 7.50%
Lasix: 2 people, 5.00%
Metopirone: 2 people, 5.00%
Metformin Hydrochloride: 2 people, 5.00%
Meclizine: 2 people, 5.00%
Lisinopril: 2 people, 5.00%

What are other side effects people have besides Eating disorder? *

Fatigue (feeling of tiredness): 10 people, 25.00%
Nausea (feeling of having an urge to vomit): 9 people, 22.50%
Dizziness: 7 people, 17.50%
Pain In Extremity: 7 people, 17.50%
Stress And Anxiety: 6 people, 15.00%
Pain: 5 people, 12.50%
Joint Pain: 5 people, 12.50%
Weight Decreased: 5 people, 12.50%
Sinus Disorder (disease of sinus): 4 people, 10.00%
Weakness: 4 people, 10.00%

What are the existing conditions these people have? *

Hyperlipidaemia (presence of excess lipids in the blood): 7 people, 17.50%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 10.00%
Hypotonia (low muscle tone): 2 people, 5.00%
Dyspnea (difficult or laboured breathing): 2 people, 5.00%
Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 5.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 5.00%
Cardiac Disorder: 2 people, 5.00%
Asthma: 2 people, 5.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 5.00%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Repatha and have Eating disorder?

- Check whether Eating disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Repatha:

Repatha (156,258 reports)

Eating disorder treatments and more:

Eating disorder (27,588 reports)

Browse all side effects of Repatha:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eating disorder:

Eating disorder (1,369 drugs)

Browse all the conditions that are associated with Eating disorder:

Eating disorder (1,447 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on evolocumab (the active ingredients of Repatha) and Repatha (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.